human hg u133 2 0 plus chip Thermo Fisher Search Results


  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 83
    Thermo Fisher chip based platform gpl570
    Chip Based Platform Gpl570, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 83/100, based on 14 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/chip based platform gpl570/product/Thermo Fisher
    Average 83 stars, based on 14 article reviews
    Price from $9.99 to $1999.99
    chip based platform gpl570 - by Bioz Stars, 2020-01
    83/100 stars
      Buy from Supplier

    99
    Thermo Fisher gpl570
    Comparison of the mRNA expression levels of CD147 and All_Genes in cancer cell lines from different <t>microarray</t> platforms ( A ) Expression values were obtained from CCLE. Five microarray platforms that have been exploited to generate transcriptome values in the NCI60: ( B ) Agilent WHG (Agilent Technologies; containing 41,000 probes), ( C ) Human Genome U133 Plus 2.0 (HG-U133 Plus 2.0; approximately 47,000 features), ( D ) Human Genome U133 (HG-U133a and b; approximately 44,000 features), ( E ) Affymetrix Human Genome U95 (HG-U95; approximately 60,000 features; Affymetrix Inc.) and ( F ) Affymetrix GeneChip Human Exon 1.0 ST (GH Exon 1.0 ST; approximately 850,000 features). The GC robust multi-array average (GCRMA) was used to normalize HG-U133 and HG-U95 arrays, whereas RMA was exploited for HG-U133 Plus 2.0 and HuEx 1.0 normalization. **** P
    Gpl570, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 723 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gpl570/product/Thermo Fisher
    Average 99 stars, based on 723 article reviews
    Price from $9.99 to $1999.99
    gpl570 - by Bioz Stars, 2020-01
    99/100 stars
      Buy from Supplier

    78
    Thermo Fisher human hg u133 plus 2 0 chip
    Comparison of the mRNA expression levels of CD147 and All_Genes in cancer cell lines from different <t>microarray</t> platforms ( A ) Expression values were obtained from CCLE. Five microarray platforms that have been exploited to generate transcriptome values in the NCI60: ( B ) Agilent WHG (Agilent Technologies; containing 41,000 probes), ( C ) Human Genome U133 Plus 2.0 (HG-U133 Plus 2.0; approximately 47,000 features), ( D ) Human Genome U133 (HG-U133a and b; approximately 44,000 features), ( E ) Affymetrix Human Genome U95 (HG-U95; approximately 60,000 features; Affymetrix Inc.) and ( F ) Affymetrix GeneChip Human Exon 1.0 ST (GH Exon 1.0 ST; approximately 850,000 features). The GC robust multi-array average (GCRMA) was used to normalize HG-U133 and HG-U95 arrays, whereas RMA was exploited for HG-U133 Plus 2.0 and HuEx 1.0 normalization. **** P
    Human Hg U133 Plus 2 0 Chip, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 78/100, based on 7 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human hg u133 plus 2 0 chip/product/Thermo Fisher
    Average 78 stars, based on 7 article reviews
    Price from $9.99 to $1999.99
    human hg u133 plus 2 0 chip - by Bioz Stars, 2020-01
    78/100 stars
      Buy from Supplier

    76
    Thermo Fisher genechip hg u133 plus 2 0 affymetrix human 3 array chips
    Comparison of the mRNA expression levels of CD147 and All_Genes in cancer cell lines from different <t>microarray</t> platforms ( A ) Expression values were obtained from CCLE. Five microarray platforms that have been exploited to generate transcriptome values in the NCI60: ( B ) Agilent WHG (Agilent Technologies; containing 41,000 probes), ( C ) Human Genome U133 Plus 2.0 (HG-U133 Plus 2.0; approximately 47,000 features), ( D ) Human Genome U133 (HG-U133a and b; approximately 44,000 features), ( E ) Affymetrix Human Genome U95 (HG-U95; approximately 60,000 features; Affymetrix Inc.) and ( F ) Affymetrix GeneChip Human Exon 1.0 ST (GH Exon 1.0 ST; approximately 850,000 features). The GC robust multi-array average (GCRMA) was used to normalize HG-U133 and HG-U95 arrays, whereas RMA was exploited for HG-U133 Plus 2.0 and HuEx 1.0 normalization. **** P
    Genechip Hg U133 Plus 2 0 Affymetrix Human 3 Array Chips, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 76/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/genechip hg u133 plus 2 0 affymetrix human 3 array chips/product/Thermo Fisher
    Average 76 stars, based on 2 article reviews
    Price from $9.99 to $1999.99
    genechip hg u133 plus 2 0 affymetrix human 3 array chips - by Bioz Stars, 2020-01
    76/100 stars
      Buy from Supplier

    92
    Thermo Fisher hg u133 plus 2 affymetrix human genome u133 plus 2 0 array
    Comparison of the mRNA expression levels of CD147 and All_Genes in cancer cell lines from different <t>microarray</t> platforms ( A ) Expression values were obtained from CCLE. Five microarray platforms that have been exploited to generate transcriptome values in the NCI60: ( B ) Agilent WHG (Agilent Technologies; containing 41,000 probes), ( C ) Human Genome U133 Plus 2.0 (HG-U133 Plus 2.0; approximately 47,000 features), ( D ) Human Genome U133 (HG-U133a and b; approximately 44,000 features), ( E ) Affymetrix Human Genome U95 (HG-U95; approximately 60,000 features; Affymetrix Inc.) and ( F ) Affymetrix GeneChip Human Exon 1.0 ST (GH Exon 1.0 ST; approximately 850,000 features). The GC robust multi-array average (GCRMA) was used to normalize HG-U133 and HG-U95 arrays, whereas RMA was exploited for HG-U133 Plus 2.0 and HuEx 1.0 normalization. **** P
    Hg U133 Plus 2 Affymetrix Human Genome U133 Plus 2 0 Array, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 92/100, based on 95 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hg u133 plus 2 affymetrix human genome u133 plus 2 0 array/product/Thermo Fisher
    Average 92 stars, based on 95 article reviews
    Price from $9.99 to $1999.99
    hg u133 plus 2 affymetrix human genome u133 plus 2 0 array - by Bioz Stars, 2020-01
    92/100 stars
      Buy from Supplier

    77
    Thermo Fisher hg u133a plus 2 0 oligonucleotide arrays
    Comparison of the mRNA expression levels of CD147 and All_Genes in cancer cell lines from different <t>microarray</t> platforms ( A ) Expression values were obtained from CCLE. Five microarray platforms that have been exploited to generate transcriptome values in the NCI60: ( B ) Agilent WHG (Agilent Technologies; containing 41,000 probes), ( C ) Human Genome U133 Plus 2.0 (HG-U133 Plus 2.0; approximately 47,000 features), ( D ) Human Genome U133 (HG-U133a and b; approximately 44,000 features), ( E ) Affymetrix Human Genome U95 (HG-U95; approximately 60,000 features; Affymetrix Inc.) and ( F ) Affymetrix GeneChip Human Exon 1.0 ST (GH Exon 1.0 ST; approximately 850,000 features). The GC robust multi-array average (GCRMA) was used to normalize HG-U133 and HG-U95 arrays, whereas RMA was exploited for HG-U133 Plus 2.0 and HuEx 1.0 normalization. **** P
    Hg U133a Plus 2 0 Oligonucleotide Arrays, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 77/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hg u133a plus 2 0 oligonucleotide arrays/product/Thermo Fisher
    Average 77 stars, based on 4 article reviews
    Price from $9.99 to $1999.99
    hg u133a plus 2 0 oligonucleotide arrays - by Bioz Stars, 2020-01
    77/100 stars
      Buy from Supplier

    78
    Thermo Fisher human genome gene chip hg u133 plus 2 0
    Comparison of the mRNA expression levels of CD147 and All_Genes in cancer cell lines from different <t>microarray</t> platforms ( A ) Expression values were obtained from CCLE. Five microarray platforms that have been exploited to generate transcriptome values in the NCI60: ( B ) Agilent WHG (Agilent Technologies; containing 41,000 probes), ( C ) Human Genome U133 Plus 2.0 (HG-U133 Plus 2.0; approximately 47,000 features), ( D ) Human Genome U133 (HG-U133a and b; approximately 44,000 features), ( E ) Affymetrix Human Genome U95 (HG-U95; approximately 60,000 features; Affymetrix Inc.) and ( F ) Affymetrix GeneChip Human Exon 1.0 ST (GH Exon 1.0 ST; approximately 850,000 features). The GC robust multi-array average (GCRMA) was used to normalize HG-U133 and HG-U95 arrays, whereas RMA was exploited for HG-U133 Plus 2.0 and HuEx 1.0 normalization. **** P
    Human Genome Gene Chip Hg U133 Plus 2 0, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 78/100, based on 7 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human genome gene chip hg u133 plus 2 0/product/Thermo Fisher
    Average 78 stars, based on 7 article reviews
    Price from $9.99 to $1999.99
    human genome gene chip hg u133 plus 2 0 - by Bioz Stars, 2020-01
    78/100 stars
      Buy from Supplier

    77
    Thermo Fisher human hg u133 plus 2 0 oligonucleotide microarrays chip
    Comparison of the mRNA expression levels of CD147 and All_Genes in cancer cell lines from different <t>microarray</t> platforms ( A ) Expression values were obtained from CCLE. Five microarray platforms that have been exploited to generate transcriptome values in the NCI60: ( B ) Agilent WHG (Agilent Technologies; containing 41,000 probes), ( C ) Human Genome U133 Plus 2.0 (HG-U133 Plus 2.0; approximately 47,000 features), ( D ) Human Genome U133 (HG-U133a and b; approximately 44,000 features), ( E ) Affymetrix Human Genome U95 (HG-U95; approximately 60,000 features; Affymetrix Inc.) and ( F ) Affymetrix GeneChip Human Exon 1.0 ST (GH Exon 1.0 ST; approximately 850,000 features). The GC robust multi-array average (GCRMA) was used to normalize HG-U133 and HG-U95 arrays, whereas RMA was exploited for HG-U133 Plus 2.0 and HuEx 1.0 normalization. **** P
    Human Hg U133 Plus 2 0 Oligonucleotide Microarrays Chip, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 77/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human hg u133 plus 2 0 oligonucleotide microarrays chip/product/Thermo Fisher
    Average 77 stars, based on 4 article reviews
    Price from $9.99 to $1999.99
    human hg u133 plus 2 0 oligonucleotide microarrays chip - by Bioz Stars, 2020-01
    77/100 stars
      Buy from Supplier

    84
    Thermo Fisher human gene chip hg u133 plus 2 0 arrays
    Comparison of the mRNA expression levels of CD147 and All_Genes in cancer cell lines from different <t>microarray</t> platforms ( A ) Expression values were obtained from CCLE. Five microarray platforms that have been exploited to generate transcriptome values in the NCI60: ( B ) Agilent WHG (Agilent Technologies; containing 41,000 probes), ( C ) Human Genome U133 Plus 2.0 (HG-U133 Plus 2.0; approximately 47,000 features), ( D ) Human Genome U133 (HG-U133a and b; approximately 44,000 features), ( E ) Affymetrix Human Genome U95 (HG-U95; approximately 60,000 features; Affymetrix Inc.) and ( F ) Affymetrix GeneChip Human Exon 1.0 ST (GH Exon 1.0 ST; approximately 850,000 features). The GC robust multi-array average (GCRMA) was used to normalize HG-U133 and HG-U95 arrays, whereas RMA was exploited for HG-U133 Plus 2.0 and HuEx 1.0 normalization. **** P
    Human Gene Chip Hg U133 Plus 2 0 Arrays, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 84/100, based on 8 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human gene chip hg u133 plus 2 0 arrays/product/Thermo Fisher
    Average 84 stars, based on 8 article reviews
    Price from $9.99 to $1999.99
    human gene chip hg u133 plus 2 0 arrays - by Bioz Stars, 2020-01
    84/100 stars
      Buy from Supplier

    99
    Thermo Fisher hg u133 plus 2 0 array
    Comparison of the mRNA expression levels of CD147 and All_Genes in cancer cell lines from different <t>microarray</t> platforms ( A ) Expression values were obtained from CCLE. Five microarray platforms that have been exploited to generate transcriptome values in the NCI60: ( B ) Agilent WHG (Agilent Technologies; containing 41,000 probes), ( C ) Human Genome U133 Plus 2.0 (HG-U133 Plus 2.0; approximately 47,000 features), ( D ) Human Genome U133 (HG-U133a and b; approximately 44,000 features), ( E ) Affymetrix Human Genome U95 (HG-U95; approximately 60,000 features; Affymetrix Inc.) and ( F ) Affymetrix GeneChip Human Exon 1.0 ST (GH Exon 1.0 ST; approximately 850,000 features). The GC robust multi-array average (GCRMA) was used to normalize HG-U133 and HG-U95 arrays, whereas RMA was exploited for HG-U133 Plus 2.0 and HuEx 1.0 normalization. **** P
    Hg U133 Plus 2 0 Array, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 367 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hg u133 plus 2 0 array/product/Thermo Fisher
    Average 99 stars, based on 367 article reviews
    Price from $9.99 to $1999.99
    hg u133 plus 2 0 array - by Bioz Stars, 2020-01
    99/100 stars
      Buy from Supplier

    99
    Thermo Fisher hg u133 plus 2 0
    Comparison of the mRNA expression levels of CD147 and All_Genes in cancer cell lines from different <t>microarray</t> platforms ( A ) Expression values were obtained from CCLE. Five microarray platforms that have been exploited to generate transcriptome values in the NCI60: ( B ) Agilent WHG (Agilent Technologies; containing 41,000 probes), ( C ) Human Genome U133 Plus 2.0 (HG-U133 Plus 2.0; approximately 47,000 features), ( D ) Human Genome U133 (HG-U133a and b; approximately 44,000 features), ( E ) Affymetrix Human Genome U95 (HG-U95; approximately 60,000 features; Affymetrix Inc.) and ( F ) Affymetrix GeneChip Human Exon 1.0 ST (GH Exon 1.0 ST; approximately 850,000 features). The GC robust multi-array average (GCRMA) was used to normalize HG-U133 and HG-U95 arrays, whereas RMA was exploited for HG-U133 Plus 2.0 and HuEx 1.0 normalization. **** P
    Hg U133 Plus 2 0, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 254 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hg u133 plus 2 0/product/Thermo Fisher
    Average 99 stars, based on 254 article reviews
    Price from $9.99 to $1999.99
    hg u133 plus 2 0 - by Bioz Stars, 2020-01
    99/100 stars
      Buy from Supplier

    79
    Thermo Fisher hg u133 plus 2 0 microarray chip
    Comparison of the mRNA expression levels of CD147 and All_Genes in cancer cell lines from different <t>microarray</t> platforms ( A ) Expression values were obtained from CCLE. Five microarray platforms that have been exploited to generate transcriptome values in the NCI60: ( B ) Agilent WHG (Agilent Technologies; containing 41,000 probes), ( C ) Human Genome U133 Plus 2.0 (HG-U133 Plus 2.0; approximately 47,000 features), ( D ) Human Genome U133 (HG-U133a and b; approximately 44,000 features), ( E ) Affymetrix Human Genome U95 (HG-U95; approximately 60,000 features; Affymetrix Inc.) and ( F ) Affymetrix GeneChip Human Exon 1.0 ST (GH Exon 1.0 ST; approximately 850,000 features). The GC robust multi-array average (GCRMA) was used to normalize HG-U133 and HG-U95 arrays, whereas RMA was exploited for HG-U133 Plus 2.0 and HuEx 1.0 normalization. **** P
    Hg U133 Plus 2 0 Microarray Chip, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 79/100, based on 16 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hg u133 plus 2 0 microarray chip/product/Thermo Fisher
    Average 79 stars, based on 16 article reviews
    Price from $9.99 to $1999.99
    hg u133 plus 2 0 microarray chip - by Bioz Stars, 2020-01
    79/100 stars
      Buy from Supplier

    78
    Thermo Fisher human genome hg u133 2 0
    Comparison of the mRNA expression levels of CD147 and All_Genes in cancer cell lines from different <t>microarray</t> platforms ( A ) Expression values were obtained from CCLE. Five microarray platforms that have been exploited to generate transcriptome values in the NCI60: ( B ) Agilent WHG (Agilent Technologies; containing 41,000 probes), ( C ) Human Genome U133 Plus 2.0 (HG-U133 Plus 2.0; approximately 47,000 features), ( D ) Human Genome U133 (HG-U133a and b; approximately 44,000 features), ( E ) Affymetrix Human Genome U95 (HG-U95; approximately 60,000 features; Affymetrix Inc.) and ( F ) Affymetrix GeneChip Human Exon 1.0 ST (GH Exon 1.0 ST; approximately 850,000 features). The GC robust multi-array average (GCRMA) was used to normalize HG-U133 and HG-U95 arrays, whereas RMA was exploited for HG-U133 Plus 2.0 and HuEx 1.0 normalization. **** P
    Human Genome Hg U133 2 0, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 78/100, based on 6 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human genome hg u133 2 0/product/Thermo Fisher
    Average 78 stars, based on 6 article reviews
    Price from $9.99 to $1999.99
    human genome hg u133 2 0 - by Bioz Stars, 2020-01
    78/100 stars
      Buy from Supplier

    77
    Thermo Fisher genechips hg u133 2 0
    Comparison of the mRNA expression levels of CD147 and All_Genes in cancer cell lines from different <t>microarray</t> platforms ( A ) Expression values were obtained from CCLE. Five microarray platforms that have been exploited to generate transcriptome values in the NCI60: ( B ) Agilent WHG (Agilent Technologies; containing 41,000 probes), ( C ) Human Genome U133 Plus 2.0 (HG-U133 Plus 2.0; approximately 47,000 features), ( D ) Human Genome U133 (HG-U133a and b; approximately 44,000 features), ( E ) Affymetrix Human Genome U95 (HG-U95; approximately 60,000 features; Affymetrix Inc.) and ( F ) Affymetrix GeneChip Human Exon 1.0 ST (GH Exon 1.0 ST; approximately 850,000 features). The GC robust multi-array average (GCRMA) was used to normalize HG-U133 and HG-U95 arrays, whereas RMA was exploited for HG-U133 Plus 2.0 and HuEx 1.0 normalization. **** P
    Genechips Hg U133 2 0, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 77/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/genechips hg u133 2 0/product/Thermo Fisher
    Average 77 stars, based on 3 article reviews
    Price from $9.99 to $1999.99
    genechips hg u133 2 0 - by Bioz Stars, 2020-01
    77/100 stars
      Buy from Supplier

    78
    Thermo Fisher gene chip hg u133 plus 2 0 u133 arrays
    Comparison of the mRNA expression levels of CD147 and All_Genes in cancer cell lines from different <t>microarray</t> platforms ( A ) Expression values were obtained from CCLE. Five microarray platforms that have been exploited to generate transcriptome values in the NCI60: ( B ) Agilent WHG (Agilent Technologies; containing 41,000 probes), ( C ) Human Genome U133 Plus 2.0 (HG-U133 Plus 2.0; approximately 47,000 features), ( D ) Human Genome U133 (HG-U133a and b; approximately 44,000 features), ( E ) Affymetrix Human Genome U95 (HG-U95; approximately 60,000 features; Affymetrix Inc.) and ( F ) Affymetrix GeneChip Human Exon 1.0 ST (GH Exon 1.0 ST; approximately 850,000 features). The GC robust multi-array average (GCRMA) was used to normalize HG-U133 and HG-U95 arrays, whereas RMA was exploited for HG-U133 Plus 2.0 and HuEx 1.0 normalization. **** P
    Gene Chip Hg U133 Plus 2 0 U133 Arrays, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 78/100, based on 7 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gene chip hg u133 plus 2 0 u133 arrays/product/Thermo Fisher
    Average 78 stars, based on 7 article reviews
    Price from $9.99 to $1999.99
    gene chip hg u133 plus 2 0 u133 arrays - by Bioz Stars, 2020-01
    78/100 stars
      Buy from Supplier

    80
    Thermo Fisher leishmania major infected dendritic cells
    Comparison of the mRNA expression levels of CD147 and All_Genes in cancer cell lines from different <t>microarray</t> platforms ( A ) Expression values were obtained from CCLE. Five microarray platforms that have been exploited to generate transcriptome values in the NCI60: ( B ) Agilent WHG (Agilent Technologies; containing 41,000 probes), ( C ) Human Genome U133 Plus 2.0 (HG-U133 Plus 2.0; approximately 47,000 features), ( D ) Human Genome U133 (HG-U133a and b; approximately 44,000 features), ( E ) Affymetrix Human Genome U95 (HG-U95; approximately 60,000 features; Affymetrix Inc.) and ( F ) Affymetrix GeneChip Human Exon 1.0 ST (GH Exon 1.0 ST; approximately 850,000 features). The GC robust multi-array average (GCRMA) was used to normalize HG-U133 and HG-U95 arrays, whereas RMA was exploited for HG-U133 Plus 2.0 and HuEx 1.0 normalization. **** P
    Leishmania Major Infected Dendritic Cells, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 80/100, based on 6 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/leishmania major infected dendritic cells/product/Thermo Fisher
    Average 80 stars, based on 6 article reviews
    Price from $9.99 to $1999.99
    leishmania major infected dendritic cells - by Bioz Stars, 2020-01
    80/100 stars
      Buy from Supplier

    86
    Thermo Fisher human u133 plus 2 0
    Comparison of the mRNA expression levels of CD147 and All_Genes in cancer cell lines from different <t>microarray</t> platforms ( A ) Expression values were obtained from CCLE. Five microarray platforms that have been exploited to generate transcriptome values in the NCI60: ( B ) Agilent WHG (Agilent Technologies; containing 41,000 probes), ( C ) Human Genome U133 Plus 2.0 (HG-U133 Plus 2.0; approximately 47,000 features), ( D ) Human Genome U133 (HG-U133a and b; approximately 44,000 features), ( E ) Affymetrix Human Genome U95 (HG-U95; approximately 60,000 features; Affymetrix Inc.) and ( F ) Affymetrix GeneChip Human Exon 1.0 ST (GH Exon 1.0 ST; approximately 850,000 features). The GC robust multi-array average (GCRMA) was used to normalize HG-U133 and HG-U95 arrays, whereas RMA was exploited for HG-U133 Plus 2.0 and HuEx 1.0 normalization. **** P
    Human U133 Plus 2 0, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 63 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human u133 plus 2 0/product/Thermo Fisher
    Average 86 stars, based on 63 article reviews
    Price from $9.99 to $1999.99
    human u133 plus 2 0 - by Bioz Stars, 2020-01
    86/100 stars
      Buy from Supplier

    87
    Thermo Fisher hg u133 plus 2 0 genechip microarrays
    Comparison of the mRNA expression levels of CD147 and All_Genes in cancer cell lines from different <t>microarray</t> platforms ( A ) Expression values were obtained from CCLE. Five microarray platforms that have been exploited to generate transcriptome values in the NCI60: ( B ) Agilent WHG (Agilent Technologies; containing 41,000 probes), ( C ) Human Genome U133 Plus 2.0 (HG-U133 Plus 2.0; approximately 47,000 features), ( D ) Human Genome U133 (HG-U133a and b; approximately 44,000 features), ( E ) Affymetrix Human Genome U95 (HG-U95; approximately 60,000 features; Affymetrix Inc.) and ( F ) Affymetrix GeneChip Human Exon 1.0 ST (GH Exon 1.0 ST; approximately 850,000 features). The GC robust multi-array average (GCRMA) was used to normalize HG-U133 and HG-U95 arrays, whereas RMA was exploited for HG-U133 Plus 2.0 and HuEx 1.0 normalization. **** P
    Hg U133 Plus 2 0 Genechip Microarrays, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 87/100, based on 66 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hg u133 plus 2 0 genechip microarrays/product/Thermo Fisher
    Average 87 stars, based on 66 article reviews
    Price from $9.99 to $1999.99
    hg u133 plus 2 0 genechip microarrays - by Bioz Stars, 2020-01
    87/100 stars
      Buy from Supplier

    78
    Thermo Fisher hg u133 plus 2 affymetrix human genome u133 plus 2 0 array detection
    Comparison of the mRNA expression levels of CD147 and All_Genes in cancer cell lines from different <t>microarray</t> platforms ( A ) Expression values were obtained from CCLE. Five microarray platforms that have been exploited to generate transcriptome values in the NCI60: ( B ) Agilent WHG (Agilent Technologies; containing 41,000 probes), ( C ) Human Genome U133 Plus 2.0 (HG-U133 Plus 2.0; approximately 47,000 features), ( D ) Human Genome U133 (HG-U133a and b; approximately 44,000 features), ( E ) Affymetrix Human Genome U95 (HG-U95; approximately 60,000 features; Affymetrix Inc.) and ( F ) Affymetrix GeneChip Human Exon 1.0 ST (GH Exon 1.0 ST; approximately 850,000 features). The GC robust multi-array average (GCRMA) was used to normalize HG-U133 and HG-U95 arrays, whereas RMA was exploited for HG-U133 Plus 2.0 and HuEx 1.0 normalization. **** P
    Hg U133 Plus 2 Affymetrix Human Genome U133 Plus 2 0 Array Detection, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 78/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hg u133 plus 2 affymetrix human genome u133 plus 2 0 array detection/product/Thermo Fisher
    Average 78 stars, based on 3 article reviews
    Price from $9.99 to $1999.99
    hg u133 plus 2 affymetrix human genome u133 plus 2 0 array detection - by Bioz Stars, 2020-01
    78/100 stars
      Buy from Supplier

    78
    Thermo Fisher gpl570 hg u133 plus 2 affymetrix human genome u133 plus 2 0 array
    Comparison of the mRNA expression levels of CD147 and All_Genes in cancer cell lines from different <t>microarray</t> platforms ( A ) Expression values were obtained from CCLE. Five microarray platforms that have been exploited to generate transcriptome values in the NCI60: ( B ) Agilent WHG (Agilent Technologies; containing 41,000 probes), ( C ) Human Genome U133 Plus 2.0 (HG-U133 Plus 2.0; approximately 47,000 features), ( D ) Human Genome U133 (HG-U133a and b; approximately 44,000 features), ( E ) Affymetrix Human Genome U95 (HG-U95; approximately 60,000 features; Affymetrix Inc.) and ( F ) Affymetrix GeneChip Human Exon 1.0 ST (GH Exon 1.0 ST; approximately 850,000 features). The GC robust multi-array average (GCRMA) was used to normalize HG-U133 and HG-U95 arrays, whereas RMA was exploited for HG-U133 Plus 2.0 and HuEx 1.0 normalization. **** P
    Gpl570 Hg U133 Plus 2 Affymetrix Human Genome U133 Plus 2 0 Array, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 78/100, based on 6 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gpl570 hg u133 plus 2 affymetrix human genome u133 plus 2 0 array/product/Thermo Fisher
    Average 78 stars, based on 6 article reviews
    Price from $9.99 to $1999.99
    gpl570 hg u133 plus 2 affymetrix human genome u133 plus 2 0 array - by Bioz Stars, 2020-01
    78/100 stars
      Buy from Supplier

    93
    Thermo Fisher oligonucleotide microarray
    Only modest increases in NIS mRNA expression were detected in tRA- and tRA/H-treated MCF-7 breast cancer cells by the 211123_at NIS probe set . MCF-7 human breast cancer cells were treated with DMSO vehicle, tRA(1 μM) or tRA(1 μM)/H(1 μM) for 12 hours, total RNA was harvested, and NIS mRNA was detected by parallel qRT-PCR and <t>microarray</t> (HG U133 Plus 2.0) experiments. The quantification of hNIS by qRT-PCR was normalized according to the level of GAPDH and the data are presented as a fold change in NIS mRNA over GAPDH control. (A) While qRT-PCR detected 7.0- and 12.6-fold increases in NIS mRNA with tRA and tRA/H treatments, respectively, only 2.1- and 2.4-fold increases were detected by microarray. The mean ± standard deviations of two independent trials are plotted. (B) Signal intensities detected by the 11 individual perfect match probes within the NIS probe set are depicted for two independent trials of DMSO-, tRA- and tRA/H-treated MCF-7 cells. The figure depicts variability in the extent of change in NIS mRNA among all 11 probes with tRA and tRA/H treatment. Fold changes in normalized NIS mRNA levels are also indicated for each individual trial.
    Oligonucleotide Microarray, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 93/100, based on 239 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/oligonucleotide microarray/product/Thermo Fisher
    Average 93 stars, based on 239 article reviews
    Price from $9.99 to $1999.99
    oligonucleotide microarray - by Bioz Stars, 2020-01
    93/100 stars
      Buy from Supplier

    80
    Thermo Fisher hg u133 plus 2 0 genechip pan genomic oligonucleotide arrays
    Only modest increases in NIS mRNA expression were detected in tRA- and tRA/H-treated MCF-7 breast cancer cells by the 211123_at NIS probe set . MCF-7 human breast cancer cells were treated with DMSO vehicle, tRA(1 μM) or tRA(1 μM)/H(1 μM) for 12 hours, total RNA was harvested, and NIS mRNA was detected by parallel qRT-PCR and <t>microarray</t> (HG U133 Plus 2.0) experiments. The quantification of hNIS by qRT-PCR was normalized according to the level of GAPDH and the data are presented as a fold change in NIS mRNA over GAPDH control. (A) While qRT-PCR detected 7.0- and 12.6-fold increases in NIS mRNA with tRA and tRA/H treatments, respectively, only 2.1- and 2.4-fold increases were detected by microarray. The mean ± standard deviations of two independent trials are plotted. (B) Signal intensities detected by the 11 individual perfect match probes within the NIS probe set are depicted for two independent trials of DMSO-, tRA- and tRA/H-treated MCF-7 cells. The figure depicts variability in the extent of change in NIS mRNA among all 11 probes with tRA and tRA/H treatment. Fold changes in normalized NIS mRNA levels are also indicated for each individual trial.
    Hg U133 Plus 2 0 Genechip Pan Genomic Oligonucleotide Arrays, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 80/100, based on 14 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hg u133 plus 2 0 genechip pan genomic oligonucleotide arrays/product/Thermo Fisher
    Average 80 stars, based on 14 article reviews
    Price from $9.99 to $1999.99
    hg u133 plus 2 0 genechip pan genomic oligonucleotide arrays - by Bioz Stars, 2020-01
    80/100 stars
      Buy from Supplier

    87
    Thermo Fisher genome wide human snp arrays 6 0
    Only modest increases in NIS mRNA expression were detected in tRA- and tRA/H-treated MCF-7 breast cancer cells by the 211123_at NIS probe set . MCF-7 human breast cancer cells were treated with DMSO vehicle, tRA(1 μM) or tRA(1 μM)/H(1 μM) for 12 hours, total RNA was harvested, and NIS mRNA was detected by parallel qRT-PCR and <t>microarray</t> (HG U133 Plus 2.0) experiments. The quantification of hNIS by qRT-PCR was normalized according to the level of GAPDH and the data are presented as a fold change in NIS mRNA over GAPDH control. (A) While qRT-PCR detected 7.0- and 12.6-fold increases in NIS mRNA with tRA and tRA/H treatments, respectively, only 2.1- and 2.4-fold increases were detected by microarray. The mean ± standard deviations of two independent trials are plotted. (B) Signal intensities detected by the 11 individual perfect match probes within the NIS probe set are depicted for two independent trials of DMSO-, tRA- and tRA/H-treated MCF-7 cells. The figure depicts variability in the extent of change in NIS mRNA among all 11 probes with tRA and tRA/H treatment. Fold changes in normalized NIS mRNA levels are also indicated for each individual trial.
    Genome Wide Human Snp Arrays 6 0, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 87/100, based on 61 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/genome wide human snp arrays 6 0/product/Thermo Fisher
    Average 87 stars, based on 61 article reviews
    Price from $9.99 to $1999.99
    genome wide human snp arrays 6 0 - by Bioz Stars, 2020-01
    87/100 stars
      Buy from Supplier

    Image Search Results


    Comparison of the mRNA expression levels of CD147 and All_Genes in cancer cell lines from different microarray platforms ( A ) Expression values were obtained from CCLE. Five microarray platforms that have been exploited to generate transcriptome values in the NCI60: ( B ) Agilent WHG (Agilent Technologies; containing 41,000 probes), ( C ) Human Genome U133 Plus 2.0 (HG-U133 Plus 2.0; approximately 47,000 features), ( D ) Human Genome U133 (HG-U133a and b; approximately 44,000 features), ( E ) Affymetrix Human Genome U95 (HG-U95; approximately 60,000 features; Affymetrix Inc.) and ( F ) Affymetrix GeneChip Human Exon 1.0 ST (GH Exon 1.0 ST; approximately 850,000 features). The GC robust multi-array average (GCRMA) was used to normalize HG-U133 and HG-U95 arrays, whereas RMA was exploited for HG-U133 Plus 2.0 and HuEx 1.0 normalization. **** P

    Journal: Oncotarget

    Article Title: System analysis of the regulation of the immune response by CD147 and FOXC1 in cancer cell lines

    doi: 10.18632/oncotarget.24161

    Figure Lengend Snippet: Comparison of the mRNA expression levels of CD147 and All_Genes in cancer cell lines from different microarray platforms ( A ) Expression values were obtained from CCLE. Five microarray platforms that have been exploited to generate transcriptome values in the NCI60: ( B ) Agilent WHG (Agilent Technologies; containing 41,000 probes), ( C ) Human Genome U133 Plus 2.0 (HG-U133 Plus 2.0; approximately 47,000 features), ( D ) Human Genome U133 (HG-U133a and b; approximately 44,000 features), ( E ) Affymetrix Human Genome U95 (HG-U95; approximately 60,000 features; Affymetrix Inc.) and ( F ) Affymetrix GeneChip Human Exon 1.0 ST (GH Exon 1.0 ST; approximately 850,000 features). The GC robust multi-array average (GCRMA) was used to normalize HG-U133 and HG-U95 arrays, whereas RMA was exploited for HG-U133 Plus 2.0 and HuEx 1.0 normalization. **** P

    Article Snippet: The reproducibility of CD147 mRNA expression measures was evaluated by comparing its transcriptional profile from the CCLE with the data from five different microarray platforms (Affymetrix HG-U95, HG-U133 a-b, HG-U133 Plus 2.0, Agilent WHG chips and Human Exon 1.0 ST) exploited in previous gene-expression studies of NCI60 ( http://discover.nci.nih.gov/cellminer/ ) [ , ], the cancer cell line collection of the National Cancer Institute Developmental Therapeutics Program (NCI-DTP).

    Techniques: Expressing, Microarray

    Only modest increases in NIS mRNA expression were detected in tRA- and tRA/H-treated MCF-7 breast cancer cells by the 211123_at NIS probe set . MCF-7 human breast cancer cells were treated with DMSO vehicle, tRA(1 μM) or tRA(1 μM)/H(1 μM) for 12 hours, total RNA was harvested, and NIS mRNA was detected by parallel qRT-PCR and microarray (HG U133 Plus 2.0) experiments. The quantification of hNIS by qRT-PCR was normalized according to the level of GAPDH and the data are presented as a fold change in NIS mRNA over GAPDH control. (A) While qRT-PCR detected 7.0- and 12.6-fold increases in NIS mRNA with tRA and tRA/H treatments, respectively, only 2.1- and 2.4-fold increases were detected by microarray. The mean ± standard deviations of two independent trials are plotted. (B) Signal intensities detected by the 11 individual perfect match probes within the NIS probe set are depicted for two independent trials of DMSO-, tRA- and tRA/H-treated MCF-7 cells. The figure depicts variability in the extent of change in NIS mRNA among all 11 probes with tRA and tRA/H treatment. Fold changes in normalized NIS mRNA levels are also indicated for each individual trial.

    Journal: BMC Research Notes

    Article Title: Microarray analysis of genes associated with cell surface NIS protein levels in breast cancer

    doi: 10.1186/1756-0500-4-397

    Figure Lengend Snippet: Only modest increases in NIS mRNA expression were detected in tRA- and tRA/H-treated MCF-7 breast cancer cells by the 211123_at NIS probe set . MCF-7 human breast cancer cells were treated with DMSO vehicle, tRA(1 μM) or tRA(1 μM)/H(1 μM) for 12 hours, total RNA was harvested, and NIS mRNA was detected by parallel qRT-PCR and microarray (HG U133 Plus 2.0) experiments. The quantification of hNIS by qRT-PCR was normalized according to the level of GAPDH and the data are presented as a fold change in NIS mRNA over GAPDH control. (A) While qRT-PCR detected 7.0- and 12.6-fold increases in NIS mRNA with tRA and tRA/H treatments, respectively, only 2.1- and 2.4-fold increases were detected by microarray. The mean ± standard deviations of two independent trials are plotted. (B) Signal intensities detected by the 11 individual perfect match probes within the NIS probe set are depicted for two independent trials of DMSO-, tRA- and tRA/H-treated MCF-7 cells. The figure depicts variability in the extent of change in NIS mRNA among all 11 probes with tRA and tRA/H treatment. Fold changes in normalized NIS mRNA levels are also indicated for each individual trial.

    Article Snippet: MCF-7 human breast cancer cells were treated with DMSO vehicle or tRA (1 μM) for 12 hours, total RNA was harvested, genome-wide expression was detected by oligonucleotide microarray (Affymetrix HG U133 Plus 2.0) and genome-wide expression was compared between treatments by Linear Model analysis.

    Techniques: Expressing, Quantitative RT-PCR, Microarray

    NIS mRNA levels detected by HG U133A oligonucleotide microarray (NIS probe set ID 211123_at) do not vary among breast tumors or normal breast tissue . The Gene Expression Omnibus dataset GSE3744 consists of normalized log 2 -transformed genome-wide expression of 7 normal breast tissues, 15 normal ER+ breast tumors and 24 ER- breast tumors. NIS and ER mRNA expression are plotted for each individual breast tissue sample and horizontal lines represent mean expression values among normal breast tissues ( light gray line ), ER+ breast tumors ( dark gray line ), and ER- breast tumors ( black line ). Mean ± standard deviation are also indicated. (A) NIS mRNA levels of breast tissues in the GSE3744 Gene Expression Omnibus dataset did not significantly vary among normal breast tissues (mean 5.1 ± 0.42, range 4.5-5.7), ER+ breast tumors (mean 5.4 ± 0.39, range 4.6-6.0) or ER- breast tumors (mean 5.2 ± 0.51, range 4.4-6.4). (B) In contrast, ER mRNA levels for normal breast tissues (mean 10.1 ± 1.56, light gray line ; range 7.4-11.9) and ER+ breast tumors (mean 10.9 ± 2.29, dark gray line ; range 5.5-13.9) were significantly greater than ER- tumors (mean 4.2 ± 1.6, black line ; range 1.9-8.2).

    Journal: BMC Research Notes

    Article Title: Microarray analysis of genes associated with cell surface NIS protein levels in breast cancer

    doi: 10.1186/1756-0500-4-397

    Figure Lengend Snippet: NIS mRNA levels detected by HG U133A oligonucleotide microarray (NIS probe set ID 211123_at) do not vary among breast tumors or normal breast tissue . The Gene Expression Omnibus dataset GSE3744 consists of normalized log 2 -transformed genome-wide expression of 7 normal breast tissues, 15 normal ER+ breast tumors and 24 ER- breast tumors. NIS and ER mRNA expression are plotted for each individual breast tissue sample and horizontal lines represent mean expression values among normal breast tissues ( light gray line ), ER+ breast tumors ( dark gray line ), and ER- breast tumors ( black line ). Mean ± standard deviation are also indicated. (A) NIS mRNA levels of breast tissues in the GSE3744 Gene Expression Omnibus dataset did not significantly vary among normal breast tissues (mean 5.1 ± 0.42, range 4.5-5.7), ER+ breast tumors (mean 5.4 ± 0.39, range 4.6-6.0) or ER- breast tumors (mean 5.2 ± 0.51, range 4.4-6.4). (B) In contrast, ER mRNA levels for normal breast tissues (mean 10.1 ± 1.56, light gray line ; range 7.4-11.9) and ER+ breast tumors (mean 10.9 ± 2.29, dark gray line ; range 5.5-13.9) were significantly greater than ER- tumors (mean 4.2 ± 1.6, black line ; range 1.9-8.2).

    Article Snippet: MCF-7 human breast cancer cells were treated with DMSO vehicle or tRA (1 μM) for 12 hours, total RNA was harvested, genome-wide expression was detected by oligonucleotide microarray (Affymetrix HG U133 Plus 2.0) and genome-wide expression was compared between treatments by Linear Model analysis.

    Techniques: Microarray, Expressing, Transformation Assay, Genome Wide, Standard Deviation

    Cell surface NIS protein levels are more variable than corresponding NIS mRNA levels detected by oligonucleotide microarray . A human breast tumor TMA composed of 28 breast tumors with corresponding cDNA microarray data was immunostained with the p442 anti-hNIS antibody and each tumor was evaluated according to the level of cell surface NIS protein on a scale of 0, 0/1+, 1+, 1+/2+, 2+ and 3+. NIS mRNA levels detected by the 211123_at NIS probe set of the HG U133 Plus 2.0 Affymetrix microarray platform were examined and compared among breast tumors expressing each assigned level of cell surface NIS protein. Maximum, minimum and median NIS mRNA levels for each level of cell surface NIS are indicated. As shown by the box and whisker plot, there was no correlation between NIS mRNA and cell surface NIS protein among breast tumors. The length of the box represents the interquartile range (i.e., the middle 50% of the data). The median ( line through the middle of each box ), the lower quartile ( bottom line of each box ), and the upper quartile ( top line of each box ) are also specified on the plot for each level of cell surface NIS protein. The sample minimum and maximum values are represented as T-shaped lines extending from the ends of the box. Maximum outliers ( gray squares ) and minimum outliers ( black diamonds ) are also plotted. Representative images of breast tumors scored as 0 (18%, n = 5), 0/1+ (21%, n = 6), 1+ (25%, n = 7), 1+/2+ (18%, n = 5), 2+ (11%, n = 3) and 3+ (7%, n = 2) for cell surface NIS protein ( denoted by arrows ) are also shown (400×).

    Journal: BMC Research Notes

    Article Title: Microarray analysis of genes associated with cell surface NIS protein levels in breast cancer

    doi: 10.1186/1756-0500-4-397

    Figure Lengend Snippet: Cell surface NIS protein levels are more variable than corresponding NIS mRNA levels detected by oligonucleotide microarray . A human breast tumor TMA composed of 28 breast tumors with corresponding cDNA microarray data was immunostained with the p442 anti-hNIS antibody and each tumor was evaluated according to the level of cell surface NIS protein on a scale of 0, 0/1+, 1+, 1+/2+, 2+ and 3+. NIS mRNA levels detected by the 211123_at NIS probe set of the HG U133 Plus 2.0 Affymetrix microarray platform were examined and compared among breast tumors expressing each assigned level of cell surface NIS protein. Maximum, minimum and median NIS mRNA levels for each level of cell surface NIS are indicated. As shown by the box and whisker plot, there was no correlation between NIS mRNA and cell surface NIS protein among breast tumors. The length of the box represents the interquartile range (i.e., the middle 50% of the data). The median ( line through the middle of each box ), the lower quartile ( bottom line of each box ), and the upper quartile ( top line of each box ) are also specified on the plot for each level of cell surface NIS protein. The sample minimum and maximum values are represented as T-shaped lines extending from the ends of the box. Maximum outliers ( gray squares ) and minimum outliers ( black diamonds ) are also plotted. Representative images of breast tumors scored as 0 (18%, n = 5), 0/1+ (21%, n = 6), 1+ (25%, n = 7), 1+/2+ (18%, n = 5), 2+ (11%, n = 3) and 3+ (7%, n = 2) for cell surface NIS protein ( denoted by arrows ) are also shown (400×).

    Article Snippet: MCF-7 human breast cancer cells were treated with DMSO vehicle or tRA (1 μM) for 12 hours, total RNA was harvested, genome-wide expression was detected by oligonucleotide microarray (Affymetrix HG U133 Plus 2.0) and genome-wide expression was compared between treatments by Linear Model analysis.

    Techniques: Microarray, Expressing, Whisker Assay

    CARS and PYROXD1 genes were identified by Pearson correlation, Spearman rank correlation, and Linear Models analyses . (A) Overlapping genes identified by the Spearman rank correlation, Pearson correlation and Linear Models microarray analyses are indicated by the venn diagram. Two PYROXD1 probesets ( denoted as PYROXD1 A and PYROXD1 B ) and CARS ( probeset ID 212971_at ) were identified by all three analyses. (B) The box and whisker plot examines and compares normalized mRNA expression of CARS and PYROXD1 among breast tumors scored as 0, 0/1+, 1+, 1+/2+, 2+ or 3+ for cell surface NIS protein. As shown by the scatter plot, CARS and PYROXD1 mRNA levels correlate with cell surface NIS protein levels. The length of the box represents the interquartile range (i.e., the middle 50% of the data). The median ( line through the middle of each box ), the lower quartile ( bottom line of each box ), and the upper quartile ( top line of each box ) are also specified on the plot for each level of cell surface NIS protein. The sample minimum and maximum values are represented as T-shaped lines extending from the ends of the box. Maximum outliers ( gray squares ) and minimum outliers ( black diamonds ) are also plotted.

    Journal: BMC Research Notes

    Article Title: Microarray analysis of genes associated with cell surface NIS protein levels in breast cancer

    doi: 10.1186/1756-0500-4-397

    Figure Lengend Snippet: CARS and PYROXD1 genes were identified by Pearson correlation, Spearman rank correlation, and Linear Models analyses . (A) Overlapping genes identified by the Spearman rank correlation, Pearson correlation and Linear Models microarray analyses are indicated by the venn diagram. Two PYROXD1 probesets ( denoted as PYROXD1 A and PYROXD1 B ) and CARS ( probeset ID 212971_at ) were identified by all three analyses. (B) The box and whisker plot examines and compares normalized mRNA expression of CARS and PYROXD1 among breast tumors scored as 0, 0/1+, 1+, 1+/2+, 2+ or 3+ for cell surface NIS protein. As shown by the scatter plot, CARS and PYROXD1 mRNA levels correlate with cell surface NIS protein levels. The length of the box represents the interquartile range (i.e., the middle 50% of the data). The median ( line through the middle of each box ), the lower quartile ( bottom line of each box ), and the upper quartile ( top line of each box ) are also specified on the plot for each level of cell surface NIS protein. The sample minimum and maximum values are represented as T-shaped lines extending from the ends of the box. Maximum outliers ( gray squares ) and minimum outliers ( black diamonds ) are also plotted.

    Article Snippet: MCF-7 human breast cancer cells were treated with DMSO vehicle or tRA (1 μM) for 12 hours, total RNA was harvested, genome-wide expression was detected by oligonucleotide microarray (Affymetrix HG U133 Plus 2.0) and genome-wide expression was compared between treatments by Linear Model analysis.

    Techniques: Microarray, Whisker Assay, Expressing